Comparison of prostaglandin E2 tablets or Foley catheter for labour induction in grand multiparas

Eastern Mediterranean Health Journal

Volumn 10, Issue 4-5, 2004, Pages 547-553

  Al Taani, M I ^a  

^a Royal Medical Services   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PROSTAGLANDIN E2; OXYTOCIC AGENT;

ADULT; ARTICLE; BALLOON CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS DISTRESS; FREQUENCY ANALYSIS; HUMAN; INTERMETHOD COMPARISON; JORDAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; MULTIPARA; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TABLET FORMULATION; UTERINE CERVIX RIPENING; BALLOON DILATATION; COMPARATIVE STUDY; DELIVERY; DRUG EFFECT; GESTATIONAL AGE; INTRAVAGINAL DRUG ADMINISTRATION; MATERNAL AGE; METHODOLOGY; PARITY; PATIENT SELECTION; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROLONGED PREGNANCY; PUBLIC HOSPITAL; SAFETY; TABLET; TIME;

ADMINISTRATION, INTRAVAGINAL; ADULT; BALLOON DILATATION; CERVICAL RIPENING; DELIVERY, OBSTETRIC; DINOPROSTONE; FEMALE; FETAL DISTRESS; GESTATIONAL AGE; HOSPITALS, MILITARY; HUMANS; JORDAN; LABOR, INDUCED; MATERNAL AGE; OXYTOCICS; PARITY; PATIENT SELECTION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, PROLONGED; PROSPECTIVE STUDIES; SAFETY; TABLETS; TIME FACTORS;

EID: 28444438850     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Steiner AL, Creasy RK. Methods of cervical ripening. Clinical obstetrics and gynecology, 1983, 26:37-46.
2. Garfield RE. Cellular and molecular bases for dystocia. Clinical obstetrics and gynecology, 1987, 30:3-18.
3. Garrett WJ. Prognostic signs of surgical induction of labour. Medical journal of Australia, 1960, 49:29.
4. Bishop EH. Pelvic scoring for elective induction. Obstetrics and gynecology, 1964, 24:266-8.
5. Anderson AM, Turnbull AC. Relationship between the length of gestation and cervical dilatation, uterine contractility and other factors during pregnancy. American journal of obstetrics and gynecology, 1969, 105:1207-14.
6. 2 in viscous gel before induction of labour. British journal of obstetrics and gynaecology, 1977, 84:264-8.
7. Trofatter KF. Cervical ripening. Clinical obstetrics and gynecology, 1992, 35: 476-85.
8. Keirse MJ N. Prostaglandins in preinduction cervical ripening. Meta-analysis of worldwide clinical experience. Journal of reproductive medicine, 1993, 38 (1 suppl.):89-100.
9. 2 gel for preinduction cervical ripening. American journal of obstetrics and gynecology, 1999, 180(1 Pt 1):55-60.
10. Mwambingu FT, Al-Meshari AA, Akiel A. The problem of grandmultiparity in current obstetric practice. International journal of gynaecology and obstetrics, 1988, 26(3):355-9.
11. Evaldson GR. The grandmultipara in modern obstetrics. Gynecologic and obstetric investigation, 1990, 30(4):217-23.
12. Babinszki A et al. Perinatal outcome in grand and great-grand multiparity: effects of parity on obstetric risk factors. American journal of obstetrics and gynecology, 1999, 181(3):669-74.
13. Goldman GA et al. The grandmultipara. European journal of obstetrics, gynecology, and reproductive biology, 1995, 61(2):105-9.
14. Abou el-Leil LA, Nasrat AA, Fayed HM. Prostaglandin E2 vaginal pessaries in the grandmultipara with an unripe cervix, a comparison of different parity groups. International journal of gynaecology and obstetrics, 1993, 40(2):119-22.
15. Yamani TY, Rouzi AA. Induction of labor with vaginal prostaglandin-E2 in grand multiparous women. International journal of gynaecology and obstetrics, 1998, 62(3):255-9.
16. Friedman EA. The labour curve. Clinics in perinatology, 1981, 8(1):15-25.
17. O'Driscoll K, Meagher D. Active management of labour. The Dublin experience, 2nd ed. London, Baillière Tindall, 1986.
18. Sobande AA, Al-Bar HM, Archibong EI. A comparison of spontaneous labor with induced vaginal tablets prostaglandin E2 in grand multiparae. Saudi medical journal, 2001, 22(8):698-701.
19. Yamani TY, Rouzi AA. Induction of labor with vaginal prostaglandin-E2 in grand multiparous women with one previous cesarean section. International journal of gynaecology and obstetrics, 1999, 65(3):251-3.
20. Lyrenas S, Clason I, Ulmsten U. In vivo controlled release of PGE2 from a vaginal insert (0.8 mm, 10 mg) during induction of labour. British journal of obstetrics and gynaecology, 2001, 108(2):169-78.
21. Ramsey PS et al. Effect of vaginal pH on efficacy of the dinoprostone gel for cervical ripening/labor induction. American journal of obstetrics and gynecology, 2002, 186(4):843-6.
22. Seeras RC. Induction of labor utilizing vaginal vs. intracervical prostaglandin E2. International journal of gynaecology and obstetrics, 1995, 48(2):163-7.
23. Nuutila M, Kajanoja P. Local administration of prostaglandin E2 for cervical ripening and labor induction: the appropriate route and dose. Acta obstetricia et gynecologica scandinavica, 1996, 75(2): 135-8.
24. St Onge RD, Connors GT. Preinduction cervical ripening: a comparison of intracervical prostaglandin E2 gel versus the Foley catheter. American journal of obstetrics and gynecology, 1995, 172(2 Pt 1):687-90.
25. Abu-Heija AT, Ali AM. Induction of labor in grand multiparous women and previous cesarean section: is it safe? Gynecologic and obstetric investigation, 2002, 53(2):121-4.
26. Ben-Aroya Z et al. Oxytocin use in grand-multiparous patients: safety and complications. Journal of maternal-fetal medicine, 2001, 10(5):328-31.
27. Toohey JS et al. The "dangerous multipara": fact or fiction? American journal of obstetrics and gynecology, 1995, 172(2 Pt 1):683-6.